Astera Labs, Inc. $ALAB Shares Sold by Vontobel Holding Ltd.

Key Points

• Vontobel Holding Ltd. reduced its stake in Astera Labs by 29.3%, selling over 12,000 shares, and now holds approximately $2.79 million worth of the stock.
• Astera Labs received mixed ratings from analysts, with Wall Street Zen downgrading it to "hold," while other analysts set price targets ranging from $120.00 to $190.00.
• Insider transactions include Director Manuel Alba selling 183,000 shares for over $31 million, resulting in a significant decrease in his ownership stake.

Vontobel Holding Ltd. lowered its position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 29.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 30,809 shares of the company's stock after selling 12,767 shares during the period. Vontobel Holding Ltd.'s holdings in Astera Labs were worth $2,786,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Fred Alger Management LLC grew its stake in Astera Labs by 13.0% during the 1st quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company's stock worth $93,087,000 after buying an additional 179,638 shares during the last quarter. Hoey Investments Inc. raised its position in Astera Labs by 22.4% in the 2nd quarter. Hoey Investments Inc. now owns 6,121 shares of the company's stock valued at $553,000 after purchasing an additional 1,121 shares during the last quarter. Wealth Effects LLC purchased a new stake in Astera Labs in the 2nd quarter valued at $242,000. Realta Investment Advisors purchased a new stake in Astera Labs in the 2nd quarter valued at $214,000. Finally, Sheets Smith Wealth Management purchased a new stake in Astera Labs in the 2nd quarter valued at $481,000. Hedge funds and other institutional investors own 60.47% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the stock. Wall Street Zen lowered shares of Astera Labs from a "buy" rating to a "hold" rating in a research note on Friday, October 3rd. CICC Research assumed coverage on Astera Labs in a report on Friday, August 29th. They set an "outperform" rating and a $190.00 price target on the stock. Northland Capmk cut Astera Labs from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, July 22nd. Northland Securities cut Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 price target for the company. in a research note on Tuesday, July 22nd. Finally, Needham & Company LLC upped their price target on Astera Labs from $100.00 to $170.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Fifteen equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, Astera Labs presently has a consensus rating of "Moderate Buy" and an average price target of $159.83.

Insider Activity at Astera Labs

In other news, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the completion of the transaction, the director owned 385,863 shares of the company's stock, valued at $66,858,482.01. The trade was a 32.17% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Jack R. Lazar sold 22,500 shares of the firm's stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $178.42, for a total transaction of $4,014,450.00. Following the transaction, the director owned 97,351 shares of the company's stock, valued at $17,369,365.42. This trade represents a 18.77% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,308,772 shares of company stock valued at $214,482,678 in the last 90 days. 12.50% of the stock is owned by corporate insiders.

Astera Labs Price Performance

Shares of ALAB stock opened at $206.21 on Friday. The firm has a market capitalization of $34.28 billion, a PE ratio of 368.23, a P/E/G ratio of 5.14 and a beta of 1.43. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90. The business's fifty day moving average price is $198.72 and its 200 day moving average price is $124.57.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, topping the consensus estimate of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. During the same period in the previous year, the firm earned $0.13 EPS. The business's revenue was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Equities research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.